Loading clinical trials...

How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ? | Clinical Trials | Clareo Health

COMPLETED

How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ?

NCT05546983•University Hospital, Strasbourg, France

Summary

Congenital heart disease is a common abnormality in newborns. The marked improvement in the surgical management of congenital heart disease has led to a reduction in postoperative mortality, historically a quality criterion for surgical and resuscitation management. With the improvement of medical knowledge and surgical techniques, mortality is no longer a single quality criterion for a center and the search for other quality criteria is essential.

Eligibility

Age

1 - 17 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Minor patients, under the age of 18
•operated at the HUS between 01/01/2010 and 03/31/2022 for transposition surgery of the great vessels (arterial switch) with or without CIV; or isolated ventricular septal closure
•Child or holders of parental authority who do not object to the reuse of their data for scientific research purposes.

Exclusion Criteria

•Transposition surgery of the great vessels associated with coarctation of the aorta, pulmonary stenosis or any other complex malformation
•Surgical technique different from the arterial switch for the transpositions of the great vessels
•Closure of interventricular communication associated with another complex heart malformation (tetralogy of Fallot, atrioventricular canal, right ventricle with double outlet, etc.)
•Child or holders of parental authority who have expressed their opposition to the reuse of their data for scientific research purposes.

Locations (1)

Service de Pédiatrie 1 - CHU de Strasbourg - France

Strasbourg, France

Key Dates

Start Date

September 1, 2022

Primary Completion Date

July 1, 2023

Completion Date

September 1, 2023

Last Updated

December 14, 2023

Enrollment

189

ACTUAL participants

Conditions

Congenital Heart Disease in Children

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

NCT04217421

Congenital Heart Disease in ChildrenNeuroprotection

View study

ACTIVE_NOT_RECRUITINGNA

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

NCT05268094

Congenital Heart Disease in Children

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ?

Inclusion Criteria

Exclusion Criteria

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

To Assess the Efficacy of Early Administration of Energy Enriched and Protein Enriched Formula in Post Cardiac Repair Infants: a Randomized Controlled Trial, Comparative Study

Adherence to Palivizumab Prophylaxis